Smirnoff switches over to Weber's health practice

Share this article:
Smirnoff switches over to Weber's health practice
Smirnoff switches over to Weber's health practice

PR firm Weber Shandwick announced Susan Smirnoff will join the agency's health practice as EVP/senior counselor.

Smirnoff joins Weber from another New York-based shop, Ruder Finn, where she had spent 33 years and co-led the agency's US healthcare practice. She also had worked as a senior counselor in the agency's healthcare and corporate communications teams.

The veteran counselor brings deep experience in oncology and neuroscience to her new role. In a statement, Laura Schoen, president of Weber Shandwick's global healthcare practice, hailed Smirnoff's "passion for science" and "commitment to delivering programs that impact patient outcomes."

The hire follows last month's news that the US Department of Health and Human Services (HHS) added $33 million to Weber's contract in an effort to further awareness for state health insurance exchanges, according to a report from PRWeek (sub req'd).  

Earlier this year, Weber was also awarded a contract from Covered California—the organization which runs that state's health insurance exchange. The $12-million contract includes creative development, social media and collateral materials through April 2015.

In May, Weber added a healthcare specialty shop to its offerings, Element Scientific Communications.
Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...